US Patent Issued on Feb. 10 for "Long-lasting reabsorbable subcutaneous implant with sustained release of pre-concentrated pharmacologically active substance in polymer for the treatment of chronic adrenal insufficiency or hypocortisolism" (Brazilian Inventor)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,544,330, issued on Feb. 10.

"Long-lasting reabsorbable subcutaneous implant with sustained release of pre-concentrated pharmacologically active substance in polymer for the treatment of chronic adrenal insufficiency or hypocortisolism" was invented by Edson Luiz Peracchi (Curitiba, Brazil).

According to the abstract* released by the U.S. Patent & Trademark Office: "Long-acting resorbable subcutaneous implant with extended release of pre-concentrated pharmacologically active substance in polymer for treatment of chronic adrenal insufficiency. The implant is inserted subcutaneously and has continuous release of the active ingredient for an extended period of time. The implant may have ...